Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PharmaControl MQL AB
AB
Dissolved
Org 5567348569
Other research and experimental development on natural sciences and engineering · NACE 7219
Est. 2007
17 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2018
SEK 23,1M
+28% vs 2017
EBITDA margin
15.0%
+820% vs 2017
Equity ratio
40.0%
Financial strength
Net profit 2018
SEK 2,6M
+6446% vs 2017
EBITDA — year on year
SEK millions
4M
3M
2M
1M
0M
2M
2016
0M
-100%
2017
3M
+300%
2018
Key figures
Annual report 2018
Revenue
SEK 23,1M
+28%
EBITDA
SEK 3,5M
+820%
Net profit
SEK 2,6M
+6446%
Total assets
SEK 8,9M
+60%
Equity
SEK 3,5M
+276%
Employees
17
—
Company information
Legal name
PharmaControl MQL AB
Org number
5567348569
Legal form
Aktiebolag
NACE code
7219 · Other research and experimental development on natural sciences and engineering
Founded
13 juli 2007
Share capital
SEK 0
Employees
17 (FTE)
VAT registered
No
Audit selected
No
Last report
2018-08-31
Financial year
January – December
Company purpose
Bolaget skall bedriva analyslabratorium samt konsultverksamhet inom nämnda områden ävensom idka därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other research and experimental development on natural sciences and engineering
Companies in
All Sweden companies
Revenue
SEK millions
0M
7M
13M
20M
26M
17M
2016
18M
2017
23M
2018
EBITDA
SEK millions
0M
1M
2M
3M
3M
2M
2016
0M
2017
3M
2018
Income statement
SEK thousands
Item
2016
2017
2018
Revenue
16 840
18 047
23 071
Staff expenses
—
—
—
EBITDA
2 481
−480
3 457
Depreciation & amort.
−268
−267
−204
EBIT
2 213
−747
3 253
Net financials
22
−3
4
Profit before tax
3 705
−41
3 347
Tax
−822
−0
−745
Net profit
2 883
−41
2 602
Balance sheet
SEK thousands
Item
2016
2017
2018
Total assets
8 277
5 526
8 868
Equity
2 984
942
3 544
Long-term debt
0
0
0
Short-term debt
3 608
3 606
4 437
Total debt
3 608
3 606
4 437
Financial ratios
5-year trend
EBITDA margin
15.0%
This company
15.8%
Market median
-5% vs market
2016
2018
Equity ratio
40.0%
This company
38.2%
Market median
+5% vs market
2016
2018
Return on equity
73.4%
This company
18.4%
Market median
+299% vs market
2016
2018
Net profit margin
11.3%
This company
8.1%
Market median
+40% vs market
2016
2018
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
2016
2018
Debt / equity
1.50×
This company
0.62×
Market median
-142% vs market
2016
2018
Annual reports & filings
Annual report 2018
Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (2)
LC
Lisa Christina Lundkvist
Chief Executive Officer
Chief Executive Officer
2020 – 2020
EK
Erik Karl Johan Grahnat
Chief Auditor
Chief Auditor
2020 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
SA
Svend Aage Linde
Chairman
2020 – 2020
SK
Susanne Kristina Maria Rydberg
Board of Directors
2020 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of PharmaControl MQL AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lisa Christina Lundkvist
Chief Executive Officer
0 companies
Erik Karl Johan Grahnat
Chief Auditor
0 companies
Svend Aage Linde
Chairman
0 companies
Susanne Kristina Maria Rydberg
Board of Directors
0 companies